Evidence map›Paper›PMID 41675408›Full record

ArticlePreventive medicine reports2026

Impact of commune level social inequalities on time to diagnosis and follow-up in women with high-grade cervical lesions in Isère, France: Evidence from the French cervical cancer screening program.

Christian Balamou, Karine Zysman, Christelle M Rodrigue, Arnaud Seigneurin

Abstract read
In one paragraph

Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christian BalamouUniversité Grenoble Alpes - UGA - Adresse CS 40700 - 38058, Grenoble, France.
Karine ZysmanCentre Régional de Coordination des Dépistages des Cancers en Auvergne-Rhône-Alpes, Site de l'Isère, 38240 Meylan, France.
Christelle M RodrigueCentre Régional de Coordination des Dépistages des Cancers en Auvergne-Rhône-Alpes, Site de l'Ain, 01000 Bourg-en-Bresse, France.
Arnaud SeigneurinUniv. Grenoble Alpes, CNRS, TIMC, CHU Grenoble Alpes, 38000 Grenoble, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the impact of commune level social inequality characteristics on delays in access to cervical cancer screening, diagnosis, and initial treatment of high-grade cervical intraepithelial lesions. Methods: We conducted a retrospective cross-sectional study among asymptomatic women living in Isère (department in France) who had undergone at least one cervico-uterine smear between January 1, 2010 and December 31, 2018. Patients with positive screening results were referred for further diagnostic procedures. Social disparities were assessed using the French Deprivation Index. Results: 3060 cases of high-grade cervical intraepithelial lesions with complete diagnosis dates were included in the analysis. Women from the most socioeconomically disadvantaged quintiles experienced significantly longer diagnostic delays than women from more advantaged groups (quintile 2: 0.72 [95% confidence interval: 0.58, 0.91]; quintile 3: 0.76 [95% confidence interval: 0.60, 0.98]). No significant association was found between socioeconomic factors and delays in treatment initiation. Conclusions: Our findings indicate significantly longer times to diagnostic procedures for women from socioeconomically disadvantaged backgrounds and those with low-grade cytological abnormalities. Given the potential progression to invasive cervical cancer, it may be advisable to allocate specific resources to ensure appropriate follow-up for women with low-grade cytological lesions, particularly those residing in socioeconomically disadvantaged areas.

Indexed as

Cervical cancer screeningCervical pap smearHigh-grade intraepithelial lesionsTime to diagnosisUterine cervical neoplasmsWomen's health

Identifiers

PMID41675408
PMCPMC12887255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.